NCT06917196View on ClinicalTrials.gov

PROOF OF CONCEPT STUDY ON THE EFFICACY OF INHALATORY TARGETED IMATINIB NANOFORMULATIONS IN PULMONARY HYPERTENSION AND POST-INFLAMMATORY FIBROSIS.

RecruitingOBSERVATIONAL

Enrollment

16

Participants

Timeline

Start Date

December 4, 2023

Primary Completion Date

December 4, 2025

Study Completion Date

June 4, 2026

Conditions

Pulmonary Arterial Hypertension (PAH)Lung Fibrosis Interstitial

Trial Locations (1)

27100

RECRUITING

Fondazione IRCCS Policlinico San Matteo, Pavia

All Listed Sponsors

lead

Fondazione IRCCS Policlinico San Matteo di Pavia

OTHER